Showing results for Diabetes

It is well understood that people with diabetes have an increased risk for a number of other health complications—including cancer. Last year, when Indiana University School of Medicine researchers demonstrated that inflammation can increase risk for leukemia, they wondered if it was also the culprit that placed people with diabetes at a higher risk for […]

A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in adults slowed during medical treatment but resumed after treatment stopped. Youth on the same treatment had markedly poorer outcomes with continued disease progression both during and after the treatment. This research, funded […]

Presented on June 9 in San Francisco at the 2019 American Diabetes Association’s 79th Scientific Sessions and published in the New England Journal of Medicine, findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study show a drug that targets the immune system can delay Type 1 diabetes a median of 2 years in children and adults at […]

Indiana University researchers and physicians announced progress toward their bold goals of developing cures and preventive treatments for devastating diseases prevalent among Indiana residents.

Indiana University School of Medicine was recently awarded a five-year, $1.9 million grant by to study diabetic retinopathy, a long-term, vision-threatening complication of diabetes.

People taking a new oral medication for Type 2 diabetes can breathe a sigh of relief concerning suspicions they might be at an increased risk for many types of cancer, according to Indiana University researchers.

Indiana University School of Medicine will continue its nationally recognized work in the scientific discovery of innovative medical treatments and care for children with the appointment of Raghu G. Mirmira, MD, PhD, as director of the school’s Herman B Wells Center for Pediatric Research, which is associated with Riley Hospital for Children at IU Health.

The award recognizes outstanding IUPUI researchers who show great promise in becoming nationally and internationally known for their accomplishments.

David Marrero, an Indiana University School of Medicine researcher and a leader in research that supported a change in Medicare reimbursement announced today, is available to discuss the importance of widespread efforts to prevent type 2 diabetes.